Your take?

Martin Shrkeli’s former drug company goes under

Well, sort of. According to reports, KaloBios Pharmaceuticals has reportedly filed for Chapter 11 bankruptcy listing more than $1.9m in debt and more than $8.1m in assets. Trouble for the company is mounting, considering, Nasdaq informed the company that because of Shrkeli’s deceit on the stock market — they would be delisted come 25 December.

(Visited 18 times, 1 visits today)
READ  Julian Assange breaks his silence on those pesky rape allegations
Sultan Khan & Amaral Jade
Sultan And Amaral Khan are respectively the Senior Editors and the Editor In Chief of The Daily News. The Khan's cover dozens of topics in their duties, and, serve over an editorial staff of 5. To contact Sultan Khan The Editor In Chief - Sultank91@icloud.comTo contact our newsroom: